PARP-INHIBITORS ROLE IN THE TREATMENT OF OVARIAN CANCER

被引：0
|
作者：
Mahon, Lauren [1 ]
机构：
[1] Univ Rochester, Rochester, NY USA
来源：
ONCOLOGY NURSING FORUM | 2023年 / 50卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PARP inhibitors as immune modulators in metastatic ovarian cancer treatment
    Vosahlikova, Sarka
    Holicek, Peter
    Moserova, Irena
    Hensler, Michal
    Mikyskova, Romana
    Kasikova, Lenka
    Pasuvka, Josef
    Drozenova, Jana
    Mojzisova, Katerina
    Kovar, Marek
    McNiesh, Iain
    Halaska, Michael
    Rob, Lukas
    Orsulic, Sandra
    Reinis, Milan
    Galluzzi, Lorenzo
    Spisek, Radek
    Fucikova, Jitka Palich
    CANCER RESEARCH, 2024, 84 (22)
  • [42] Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
    Grech, Christina T.
    Pils, Dietmar
    Aust, Stefanie
    Grimm, Christoph
    Polterauer, Stephan
    Reinthaller, Alexander
    Muellauer, Leonhard
    Reischer, Theresa
    Bekos, Christine
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [43] Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
    Bartoletti, Michele
    Pelizzari, Giacomo
    Gerratana, Lorenzo
    Bortot, Lucia
    Lombardi, Davide
    Nicoloso, Milena
    Scalone, Simona
    Giorda, Giorgio
    Baldassarre, Gustavo
    Sorio, Roberto
    Puglisi, Fabio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11)
  • [44] PARP-INHIBITORS CAN BE APPLIED TOGETHER WITH TUMOR TREATING FIELDS (TTFIELDS) TO PROLONG SURVIVAL IN AN OVARIAN CANCER MOUSE MODEL
    Berckmans, Yani
    Wouters, Roxanne
    Thirion, Gitte
    Vandenbrande, Katja
    Vergote, Ignace
    Coosemans, An
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A282 - A282
  • [45] PARP INHIBITORS IN OVARIAN CANCER THERAPY
    Pisula, Agata
    Sienicka, Agnieszka
    Dobrowolska-Redo, Agnieszka
    Kacperczyk-Bartnik, Joanna
    Romejko-Wolniewicz, Ewa
    PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (02): : 71 - 74
  • [46] PARP Inhibitors in Ovarian Cancer: A Review
    David M. O’Malley
    Thomas C. Krivak
    Nashwa Kabil
    Jiefen Munley
    Kathleen N. Moore
    Targeted Oncology, 2023, 18 : 471 - 503
  • [47] PARP Inhibitors in Ovarian Cancer Reply
    Ray-Coquard, Isabelle
    Perol, David
    Pujade-Lauraine, Eric
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1574 - 1575
  • [48] PARP inhibitors in ovarian cancer FOREWORD
    Cibula, David
    Balmana, Judith
    BRITISH JOURNAL OF CANCER, 2015, 113 : S1 - S2
  • [49] PARP Inhibitors in Breast and Ovarian Cancer
    Wang, Samuel S. Y.
    Jie, Yeo Ee
    Cheng, Sim Wey
    Ling, Goh Liuh
    Ming, Heong Valerie Yue
    CANCERS, 2023, 15 (08)
  • [50] The Maze of PARP Inhibitors in Ovarian Cancer
    Nair, Abhilasha
    Chen, Alice P.
    Pothuri, Bhavana
    ONCOLOGY-NEW YORK, 2012, 26 (02): : 136 - +
12345